Royal London Asset Management LTD Bio Rad Laboratories, Inc. Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $73,594 - $85,181	-242 Reduced 3.39%	6,895 $2.38 Million
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $281,761 - $381,831	-1,046 Reduced 12.78%	7,137 $2.3 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $215,754 - $260,340	616 Added 8.14%	8,183 $2.93 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $322,391 - $387,310	770 Added 11.33%	7,567 $3.62 Million
Q4 2022 Feb 09, 2023	BUY	$351.71 - $456.01 $368,592 - $477,898	1,048 Added 18.23%	6,797 $2.86 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $84,168 - $114,905	-204 Reduced 3.43%	5,749 $2.4 Million
Q2 2022 Sep 06, 2022	BUY	$463.67 - $597.16 $2.76 Million - $3.55 Million	5,953 New	5,953 $2.95 Million
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $2.87 Million - $3.7 Million	-6,198 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$524.57 - $735.42 $142,158 - $199,298	271 Added 4.57%	6,198 $3.49 Million
Q2 2021 Oct 18, 2022	SELL	$576.64 - $649.04 $14,992 - $16,875	-26 Reduced 0.44%	5,927 $3.82 Million
Q1 2021 Apr 13, 2021	BUY	$547.01 - $662.35 $168,479 - $204,003	308 Added 5.48%	5,927 $3.39 Million
Q4 2020 Jan 29, 2021	BUY	$510.68 - $643.45 $307,429 - $387,356	602 Added 12.0%	5,619 $3.28 Million
Q3 2020 Nov 04, 2020	BUY	$454.43 - $535.6 $2.28 Million - $2.69 Million	5,017 New	5,017 $2.59 Million
Q1 2019 Apr 30, 2019	SELL	$224.3 - $317.41 $2.61 Million - $3.7 Million	-11,645 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$220.1 - $309.0 $91,781 - $128,853	417 Added 3.71%	11,645 $2.7 Million
Q3 2018 Nov 08, 2018	SELL	$289.28 - $326.15 $139,432 - $157,204	-482 Reduced 4.12%	11,228 $0
Q2 2018 Sep 19, 2018	BUY	$244.1 - $303.88 $2.86 Million - $3.56 Million	11,710 New	11,710 $3.38 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account